HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $68.7 million in its third quarter.
The Henderson, Nevada-based company said it had a loss of 66 cents per share. Losses, adjusted for non-recurring costs, were 17 cents per share.
The biotechnology company posted revenue of $25.3 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $24.6 million.
Spectrum Pharma expects full-year revenue in the range of $100 million to $110 million.
Spectrum Pharma shares have declined 31 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $13.01, a decrease of 31 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SPPI at https://www.zacks.com/ap/SPPI